ALUR |
ALLURION TECHNOLOGIES, INC. |
Common Stock, $0.0001 par value per share |
34.1% |
$8.14M |
$4.78M |
2.54M |
+142% |
RTW Investments, LP |
Apr 15, 2025 |
ALUR |
ALLURION TECHNOLOGIES, INC. |
Common Stock, $0.0001 par value per share |
17.6% |
$452K |
|
1.05M |
0% |
RTW Investments, LP |
Feb 20, 2025 |
ESTA |
Establishment Labs Holdings Inc. |
Common Shares, No Par Value |
9.99% |
$101M |
|
2.82M |
|
RTW Investments, LP |
Dec 31, 2024 |
STOK |
Stoke Therapeutics, Inc. |
Common Stock, par value $0.0001 per share |
9.99% |
$45.2M |
|
5.31M |
|
RTW Investments, LP |
Dec 31, 2024 |
NGNE |
Neurogene Inc. |
Common Stock, par value $0.000001 per share |
9.99% |
$25.2M |
|
1.5M |
|
RTW Investments, LP |
Dec 31, 2024 |
MIST |
Milestone Pharmaceuticals Inc. |
Common Shares, no par value per share |
9.99% |
$12.9M |
|
5.64M |
|
RTW Investments, LP |
Dec 31, 2024 |
SABS |
SAB Biotherapeutics, Inc. |
Common Stock, par value $0.0001 per share |
9.99% |
$1.68M |
|
1.02M |
|
RTW Investments, LP |
Dec 31, 2024 |
AKRO |
Akero Therapeutics, Inc. |
Common Stock, par value $0.0001 per share |
9.8% |
$315M |
|
6.86M |
|
RTW Investments, LP |
Dec 31, 2024 |
PEPG |
PepGen Inc. |
Common Stock, $0.0001 par value per share |
9.8% |
$7.18M |
|
3.19M |
|
RTW Investments, LP |
Dec 31, 2024 |
AXSM |
Axsome Therapeutics, Inc. |
Common Stock, $0.0001 par value per share |
8.4% |
$481M |
|
4.05M |
|
RTW Investments, LP |
Dec 31, 2024 |
SYRE |
Spyre Therapeutics, Inc. |
Common Stock, par value $0.0001 per share |
6.2% |
$67.2M |
|
3.62M |
|
RTW Investments, LP |
Dec 31, 2024 |
APGE |
Apogee Therapeutics, Inc. |
Common Stock, $0.00001 par value per share |
6% |
$104M |
|
2.71M |
|
RTW Investments, LP |
Dec 31, 2024 |
TSHA |
Taysha Gene Therapies, Inc. |
Common Stock, par value $0.00001 per share |
5.9% |
$21.3M |
|
12.4M |
|
RTW Investments, LP |
Dec 31, 2024 |
IMTX |
Immatics N.V. |
Ordinary Shares, nominal value EURO 0.01 per share |
5.5% |
$29.8M |
|
6.54M |
|
RTW Investments, LP |
Dec 31, 2024 |
ACAD |
Acadia Pharmaceuticals Inc. |
Common Stock, par value $0.0001 per share |
5.2% |
$153M |
|
8.71M |
|
RTW Investments, LP |
Dec 31, 2024 |
DYN |
Dyne Therapeutics, Inc. |
Common Stock, par value $0.0001 per share |
5.1% |
$62.8M |
|
5.22M |
|
RTW Investments, LP |
Dec 31, 2024 |
SAGE |
Sage Therapeutics, Inc. |
Common Stock, par value $0.0001 per share |
4.9% |
$22.2M |
|
3M |
|
RTW Investments, LP |
Dec 31, 2024 |
EPIX |
ESSA Pharma Inc. |
Common Shares, no par value |
2.5% |
$1.91M |
|
1.11M |
|
RTW Investments, LP |
Dec 31, 2024 |
GERN |
Geron Corporation |
Common Stock, $0.001 par value |
0% |
$0 |
|
0 |
|
RTW Investments, LP |
Dec 31, 2024 |
CUTRQ |
Cutera, Inc. |
Common Stock, $0.001 par value |
0% |
$0 |
|
0 |
|
RTW Investments, LP |
Dec 31, 2024 |